Cleared Traditional

K930660 - CREATINE KINASE (CK) REAGENT SET

K930660 is the FDA 510(k) clearance for CREATINE KINASE (CK) REAGENT SET by Pointe Scientific, Inc.,. It is a Class 2 Chemistry device (product code CGS) cleared through the Traditional 510(k) pathway after a 48-day FDA review.

K930660 · Pointe Scientific, Inc., · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1993
Decision
48d
Days
Class 2
Risk

K930660 is an FDA 510(k) clearance for the CREATINE KINASE (CK) REAGENT SET. Classified as Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (product code CGS), Class II - Special Controls.

Submitted by Pointe Scientific, Inc., (Lincoln Park, US). The FDA issued a Cleared decision on March 29, 1993 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pointe Scientific, Inc., devices

Submission Details

510(k) Number K930660 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 09, 1993
Decision Date March 29, 1993
Days to Decision 48 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 88d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes

All 99
Devices cleared under the same product code (CGS) and FDA review panel - the closest regulatory comparables to K930660.
CREATINE KINASE TEST
K931889 · Em Diagnostic Systems, Inc. · Jul 1993
KING DIAGNOSTICS CK REAGENT
K931326 · King Diagnostics, Inc. · Jun 1993
SYNERMED CREATINE KINASE REAGENT KIT
K930932 · Synermed, Inc. · May 1993
OLYMPUS CREATINE KINASE REAGENT
K924832 · Olympus Corp. · Jan 1993
REP E-Z CK-30 ISOENZYME KIT
K925801 · Helena Laboratories · Dec 1992
CK-NAC ACTIVATED KIT
K923511 · Randox Laboratories, Ltd. · Oct 1992